Test 400 vs Test E, and Why 400 mg/mL Hurts More

Test 400 sells on one promise: less oil. Instead of 2 mL of Test E a week, you pin 1.25 mL and get the same milligrams. Then the threads start: a leg that went dead for five days, a "golf ball" in the glute, a doctor handing out antibiotics before the user worked out it was the gear.

It is the same testosterone as your Test E. So why does it hurt so much more, does it change your bloodwork, and how do you tell bad PIP from an infection? We read about 25 forum threads, pulled the official labels for every pharmaceutical testosterone, and checked what the research does and doesn't show.

Test 400 vs Test E: same hormone, different solution

Testosterone enanthate is one ester. "Test 400" is not. It is a category of underground lab (UGL) products that put 400 mg of testosterone esters into each mL, usually as a blend. Labels we saw posted included enanthate, cypionate and decanoate mixes, and older versions with up to seven esters including propionate and acetate. There is no standard formula, so two vials called Test 400 can contain different things. Our testosterone esters guide covers each ester in detail. This article is about what changes when you pack them in at 400.

No regulated injectable testosterone goes that high. Pharmaceutical intramuscular products top out at 200 to 250 mg/mL (Depo-Testosterone label; Sustanon 250 SmPC; Nebido SmPC).

How many mL you actually inject

Volume is the only real advantage of Test 400. Here is the weekly oil you inject at common doses:

Click to expand

At TRT doses the saving is a fraction of a mL a week, which is why forum veterans keep telling TRT patients not to bother. It only starts to matter on a 1 g+ blast, where 4 mL of Test E a week becomes 2.5 mL. If you need a different concentration or dose, our dosage calculator does the conversion.

Why 400 mg/mL hurts more

Testosterone esters are fat-soluble powders, and carrier oil can only dissolve so much of them. So manufacturers add co-solvents, mainly benzyl benzoate (BB). Benzyl alcohol (BA) goes in as a preservative and also helps solubility.

More hormone per mL needs more co-solvent

The official labels show the pattern. Depo-Testosterone uses the same recipe at two strengths (DailyMed):

Doubling the hormone doubled the benzyl benzoate and cut the oil. Nebido, at 250 mg/mL, carries 2,000 mg of benzyl benzoate in every 4 mL ampoule, 500 mg per mL (Nebido SmPC). Not every product follows the rule: generic enanthate at 200 mg/mL dissolves in sesame oil with no benzyl benzoate listed at all (DailyMed). How much co-solvent you need depends on the ester and the oil.

At 400 mg/mL a brewer is past every pharmaceutical recipe. One Test 400 label posted on Evolutionary.org listed 200 mg enanthate, 100 mg decanoate and 100 mg cypionate per mL, with 2% benzyl alcohol, 20% benzyl benzoate and 5% ethyl oleate in grapeseed oil. Do the rough arithmetic: 400 mg of dissolved ester takes up something like a third of a mL, and the solvents another quarter. In a Test 400 vial, oil can be the minority ingredient. In Depo-Testosterone 200 it is around 60% of the volume.

Five reasons a 400 can hurt more

No study has tested any of these head to head. They are the mechanisms that fit the formulations, and the ones experienced users keep pointing to:

1. A stronger solution in one spot. Per injection you often use less total solvent than with Test E, because the volume is smaller. But the tissue around the needle gets a depot that is denser in hormone and solvent, with less oil to buffer it.
2. Crashing. High-concentration oils crystallise when they get cold, and users describe cloudy vials that clear when warmed. Injecting crystals, or a solution that precipitates once the solvent spreads into the muscle, is a plausible cause of sterile inflammation. Our injection guide describes this mechanism, which is widely proposed but not proven.
3. Ethyl oleate. Some brewers use it to thin high-concentration oils, and several users blame it specifically for their PIP. We found no human data either way.
4. Short esters. Some Test 400 blends include propionate or acetate. Users widely report these sting more, though we found no study measuring it.
5. Sloppy brewing. A 400 mg/mL brew is harder to make well, so solvent ratios outside the normal range, poor filtering, and under- or over-dosing all become more likely.

The counterpoint: benzyl alcohol is a local anaesthetic

The "more solvent, more pain" story is less simple than the forums make it. Benzyl alcohol numbs. In small skin-injection trials, lidocaine with benzyl alcohol was 27% less painful than plain lidocaine (Williams & Howe, 1994), and 0.9% benzyl alcohol on its own was 48% less painful than saline (Wilson & Martin, 1999). Sustanon 250 itself contains 100 mg of benzyl alcohol per mL (SmPC), about ten times what Depo-Testosterone uses. Those were skin injections, not oil into muscle, so they settle nothing, but they are a reason to stop blaming benzyl alcohol by default. If something in the solvent mix is the irritant, benzyl benzoate and ethyl oleate are better suspects, and neither has been studied for this.

How much PIP is normal from any testosterone

Even pharmaceutical testosterone hurts some of the time, which matters when you are deciding whether a vial is bad:

• Weekly IM enanthate: 29.4% of 551 injections caused minor local side effects, mostly pain and bleeding (Mackey et al., 1995).
• 4 mL of undecanoate in castor oil: 80% of men reported pain, peaking straight after the injection, lasting 1 to 2 days and back to baseline by day 4 (Sartorius et al., 2010).
• Subcutaneous enanthate autoinjector (0.5 mL): over 95% reported no injection pain (Kaminetsky et al., 2019).

The forum reports for Test 400 sound different: three to seven days of pain, not one to two.

What users report on the forums

These are paraphrased from threads on Evolutionary.org, EliteFitness, UGL Talk and ASF. They are anecdotes, not data, but the same patterns keep turning up.

Most say 400 always hurts. The common line is that you can't get 400 mg into a mL without PIP, whoever brews it, and that around 300 mg/mL is where most people stop noticing. Some vendors put "not for beginners" warnings on their own Test 400.

A minority say theirs is smooth. These reports cluster in vendor review threads, and others reply that a painless Test 400 may be an underdosed one. Third-party tests posted for various Test 400s ranged from roughly 387 to 420 mg/mL, so some are close to label, but one user felt nothing at 600 mg a week for six weeks and suspected the vial.

The pain can look like an infection. Reports we read included:

• A user on 200 mg (0.5 mL) got a hot, sore thigh, saw a doctor and was given antibiotics. When the same thing happened in his other delt, he realised it was the gear.
• 0.5 mL into a pec caused heavy swelling with fluid collecting behind the nipple.
• A 2 mL (800 mg) catch-up shot into one quad caused two days of fever, a warm, swollen leg he could not bend, and a hospital ultrasound that confirmed a sterile abscess.

Their fixes:

• Mixing it in the syringe with a weaker oil. A quarter Test 400 with three quarters Test 250 was "back to no PIP" for one user. Another had no pain when Test 400 shared a syringe with EQ, and brutal pain when it did not.
• Splitting it into 0.1 to 0.33 mL shots, and never more than 0.5 mL of anything above 300 mg/mL in one spot.
• Moving to the ventrogluteal or glute, and staying off delts and pecs.
• Warming the vial before drawing.
• The most common advice of all: go back to Test 250. Several people point out that once you dilute or split it, the one advantage of Test 400 is gone.

Injection pain or infection? How to tell

Injection site trouble is common among people who inject performance drugs. In a survey of 366 men in England and Wales, 42% had ever had redness, swelling and tenderness at an injection site, and 6.8% had had an abscess or open wound. Only 17% of the first group ever saw anyone about it (Hope et al., 2015).

Real infections from steroid injections are documented, from a thigh abscess linked to shared multi-dose vials (Rich et al., 1999) to pyomyositis, a muscle infection (Shiber, 2013), and one fatal case of necrotising myofasciitis in a 31-year-old steroid user (Bertozzi et al., 2019). Staphylococcus aureus causes about half of muscle infections (29 of 60 cases in one series) (Burdette et al., 2012).

Bloodwork will not settle it on its own

It is tempting to get a CRP and white cell count and let the numbers decide. They can't. A sterile abscess raises CRP and can cause low-grade fever too. A normal white count does not rule out a deep muscle infection (Crum, 2004). CK rises with any muscle damage, including hard training. Even the score doctors use to flag necrotising infection works worst in people who inject drugs (Henry et al., 2021). What separates sterile from infected is an examination, an ultrasound, and if there is a collection, a culture from it.

Track CRP and neutrophils as supporting evidence only. A rising CRP with a hot, swollen site is a reason to get seen, and a normal one is not a reason to stay home.

A decision tree for a sore injection site

The thresholds below are general clinical guidance built around the normal pain timeline above, not cut-offs from a trial.

1. Sore from the start, peaked in the first day, clearly improving by day 2 to 4, no fever. Normal PIP. Warm compress and light movement. Do not inject that spot again until it has fully settled.
2. Still worsening after day 3 or 4, or a hard lump, but you feel well. Book a GP or urgent care visit for today or tomorrow. Mark the edge of any redness with a pen and take a photo so you can see whether it spreads.
3. Fever or chills, a soft lump that feels full of fluid, pus, red streaks running up the limb, or redness past your pen line. Same-day urgent care or emergency. Expect bloods, an ultrasound and possibly drainage.
4. Pain far worse than the site looks, dusky or blistered skin, numbness, confusion, a racing heart or feeling faint. Call emergency services. This is how necrotising infection and sepsis present.

Tell the doctor what you injected and how much, because it changes what they look for. Don't squeeze it, and don't take leftover antibiotics: an abscess usually needs draining, and a culture tells them which antibiotic will actually work.

Test 400 vs Test 250, Test 300 and Sustanon

Searches for "test 250 vs test 400" and "sustanon 400 vs 250" come down to one question: is the 400 stronger? Per mL, yes, 60% more hormone. Per milligram, no. 500 mg is 500 mg of ester whatever the concentration.

What differs slightly is how much of each milligram is actual testosterone, because heavier esters weigh more:

So at 500 mg a week:

• Test E delivers about 360 mg of testosterone.
• Sustanon 250 delivers about 352 mg (the label says each 250 mg mL holds 176 mg of testosterone).
• The posted 200 E / 100 Dec / 100 Cyp Test 400 delivers about 349 mg.

That is a 3% difference. Switching between Test E, Sustanon and a typical Test 400 at the same weekly milligrams barely changes your dose. What does change is how the dose arrives. A blend with propionate or other short esters peaks faster and dips sooner; a decanoate-heavy one takes longer to settle.

"Sustanon 400" follows the same logic. It is a UGL product with no standard recipe, not a stronger version of the pharmaceutical Sustanon 250, and the same concentration problems apply. For the two pharmaceutical products side by side, see our Sustanon 250 vs enanthate comparison.

Does Test 400 change your bloodwork at the same weekly dose?

It shouldn't, if the vial is honest. The hormone is the same, and the ester arithmetic above moves the delivered dose by only a few percent. Enanthate and cypionate behave almost identically (Schulte-Beerbühl & Nieschlag, 1980), which is why our enanthate vs cypionate comparison treats them as interchangeable.

There is one caveat. In a small nandrolone decanoate study, 1 mL of a concentrated depot was absorbed more completely than the same dose spread across 4 mL (Minto et al., 1997). The two groups compared were 5 and 6 men, and nobody has repeated it with testosterone at 400 mg/mL, so treat it as a hint that absorption can differ, not proof that Test 400 hits harder.

Using your bloods to check the vial

The forums' own test for a bad vial is bloodwork, not PIP. You can do the same with numbers from a controlled trial. In young men whose own production was shut down, weekly enanthate gave these average trough total testosterone levels (Bhasin et al., 2001):

Between 300 and 600 mg that works out at roughly 3.4 ng/dL per weekly mg, so 500 mg a week would typically land around 2,000 ng/dL (about 70 nmol/L) at trough. That is our estimate between the two measured doses, from men whose own production was switched off, and individuals vary widely with SHBG, body size and the lab's assay.

What to read from your result:

• Far below the expected range at a stable dose: the first suspect is the vial. Across 19 studies of black market steroids, 36% were counterfeit and a further 37% substandard (Magnolini et al., 2022). In a Brazilian police analysis, 65.2% of oil solutions were counterfeit (Neves & Caldas, 2017).
• Far above: an overdosed vial is possible, or you drew close to a peak rather than at trough.
• Free testosterone and estradiol: free T and estradiol follow total T. A suddenly high E2 after switching is more likely a real dose change than anything about the 400. See our estradiol on TRT guide and T:E2 ratio guide.

Underdosing is not the only risk: UGL oils can also carry heavy metals and other contaminants. We covered testing for those in heavy metals in UGL steroids.

When to test after switching

Wait for steady state, which takes about four to five half-lives, or roughly three weeks for enanthate. In practice, test 6 to 8 weeks after switching to a new product, or 8 to 12 weeks if the blend is heavy in decanoate, and draw at trough, just before an injection. Our blood test timing guide has the full schedule.

Haematocrit does not care about the label

Haematocrit and haemoglobin rise in a straight line with testosterone dose (Coviello et al., 2008). Men on enanthate every two weeks, with big peaks, had abnormal haematocrit far more often than men on patches (43.8% vs 15.4%) (Dobs et al., 1999). That suggests peaks matter, though the trial compared different routes too. Either way, Test 400 only affects haematocrit through the dose you actually get, so a properly dosed 400 at the same weekly milligrams should not change it. If yours climbs, see how to lower haematocrit on TRT, and remember that more testosterone stops buying much extra muscle well before it stops raising haematocrit.

How long is the Test 400 half-life?

There is no single number, because a blend is several esters releasing at different speeds at once. The short esters set the early peak and the long ones carry the tail. These are the verified figures we could find:

For a Test 400 made of enanthate and cypionate, treat it like Test E: most people split it into at least two injections a week, which also keeps the volume per site down. If it contains decanoate, it will take longer to reach steady state and longer to clear. If it contains propionate, expect a quicker kick and more variation between injections. Sustanon 250 itself peaks at about 70 nmol/L within 24 to 48 hours of a single dose and drops back to the low end of normal in about 21 days (Sustanon 250 SmPC).

If you already have a vial of Test 400

You don't have to throw it out. These are the methods users say work, in order of how often they come up:

1. Never put more than about 0.5 mL in one site. Split your weekly dose into two or three injections.
2. Use big, deep muscles. The ventrogluteal or glute, not delts, pecs or quads.
3. Warm the vial and check it. If it is cloudy or has crystals, warm it in your hand or warm water until it is completely clear. If it will not clear, do not inject it.
4. Dilute it in the syringe with a lower-concentration testosterone or another oil you already use. This works, but it brings your volume back up to Test 250 levels.
5. Inject slowly. Nebido's own label specifies about two minutes for a 4 mL oil injection (Nebido SmPC). The same applies to thick oil.
6. Never pin a site that is still hot or swollen from the last shot.

Basic hygiene matters more with UGL gear, because you cannot control how sterile the vial is: wash your hands, swab the stopper and the site and let both dry, use a new needle and syringe every time, and never share vials.

Practical recommendations

• On TRT (100 to 200 mg a week): stick to 200 or 250 mg/mL. The volume saving from Test 400 is under half a mL a week, which is not worth the pain.
• Blasting under about 750 mg: Test 250 or 300 is easier on your tissue and nearly as convenient.
• Blasting above about 1 g: this is the only place Test 400 earns its keep. Split it across at least three glute or ventroglute injections.
• After any switch: do a trough blood test at 6 to 8 weeks. If total T is far below what your dose predicts, the vial is the likely problem.
• Whatever the vial: know the four steps of the decision tree, and get a hot, worsening site seen.

Key takeaways

• Test 400 is the same hormone as Test E. The difference is the solution: more co-solvent and less oil per mL
• No study has tested concentration against injection pain. The forum consensus, the labels and the chemistry all point the same way, but it is unproven
• At the same weekly milligrams, typical Test 400 blends deliver within about 3% of the testosterone in Test E
• Expect a trough of roughly 2,000 ng/dL (about 70 nmol/L) at 500 mg a week of enanthate. Far below that suggests a bad vial
• PIP that is improving by day 2 to 4 is normal. Worsening after day 3 or 4, fever or spreading redness needs a doctor, and CRP alone cannot rule out infection
• The volume advantage only matters on blasts above about 1 g a week

---

References

1. Behre, H. M., Abshagen, K., Oettel, M., Hübler, D., & Nieschlag, E. (1999). Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: Phase I studies. European Journal of Endocrinology, 140(5), 414-419. PubMed
2. Bertozzi, G., Sessa, F., Maglietta, F., et al. (2019). Immunodeficiency as a side effect of anabolic androgenic steroid abuse: A case of necrotizing myofasciitis. Forensic Science, Medicine and Pathology, 15(4), 616-621. PubMed
3. Bhasin, S., Woodhouse, L., Casaburi, R., et al. (2001). Testosterone dose-response relationships in healthy young men. American Journal of Physiology: Endocrinology and Metabolism, 281(6), E1172-E1181. PubMed
4. Bond, P., Smit, D. L., & de Ronde, W. (2022). Anabolic-androgenic steroids: How do they work and what are the risks? Frontiers in Endocrinology. PubMed
5. Burdette, S. D., Watkins, R. R., Wong, K. K., et al. (2012). Staphylococcus aureus pyomyositis compared with non-Staphylococcus aureus pyomyositis. Journal of Infection, 64(5), 507-512. PubMed
6. Coviello, A. D., Kaplan, B., Lakshman, K. M., Chen, T., Singh, A. B., & Bhasin, S. (2008). Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. Journal of Clinical Endocrinology & Metabolism, 93(3), 914-919. PubMed
7. Crum, N. F. (2004). Bacterial pyomyositis in the United States. American Journal of Medicine, 117(6), 420-428. PubMed
8. Dobs, A. S., Meikle, A. W., Arver, S., et al. (1999). Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. Journal of Clinical Endocrinology & Metabolism, 84(10), 3469-3478. PubMed
9. Henry, R., Matsushima, K., Etzel, M., et al. (2021). Utility of the Laboratory Risk Indicator for Necrotizing Fasciitis score: Comorbid conditions do matter. Surgical Infections, 22(8), 797-802. PubMed
10. Hope, V. D., McVeigh, J., Marongiu, A., et al. (2015). Injection site infections and injuries in men who inject image- and performance-enhancing drugs: Prevalence, risks factors, and healthcare seeking. Epidemiology and Infection, 143(1), 132-140. PubMed
11. Kaminetsky, J. C., et al. (2019). A 52-week study of dose adjusted subcutaneous testosterone enanthate in oil self-administered via disposable auto-injector. Journal of Urology. PubMed
12. Mackey, M. A., Conway, A. J., & Handelsman, D. J. (1995). Tolerability of intramuscular injections of testosterone ester in oil vehicle. Human Reproduction, 10(4), 862-865. PubMed
13. Magnolini, R., Falcato, L., Cremonesi, A., Schori, D., & Bruggmann, P. (2022). Fake anabolic androgenic steroids on the black market: A systematic review and meta-analysis. BMC Public Health, 22, 1371. PubMed
14. Minto, C. F., Howe, C., Wishart, S., Conway, A. J., & Handelsman, D. J. (1997). Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: Effects of ester, injection site and injection volume. Journal of Pharmacology and Experimental Therapeutics, 281(1), 93-102. PubMed
15. Neves, D. B. D. J., & Caldas, E. D. (2017). GC-MS quantitative analysis of black market pharmaceutical products containing anabolic androgenic steroids seized by the Brazilian Federal Police. Forensic Science International, 275, 272-281. PubMed
16. Rich, J. D., Dickinson, B. P., Flanigan, T. P., & Valone, S. E. (1999). Abscess related to anabolic-androgenic steroid injection. Medicine & Science in Sports & Exercise, 31(2), 207-209. PubMed
17. Sartorius, G., Fennell, C., Spasevska, S., Turner, L., Conway, A. J., & Handelsman, D. J. (2010). Factors influencing time course of pain after depot oil intramuscular injection of testosterone undecanoate. Asian Journal of Andrology, 12(2), 227-233. PubMed
18. Schulte-Beerbühl, M., & Nieschlag, E. (1980). Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum after injection of testosterone enanthate or testosterone cypionate. Fertility and Sterility, 33(2), 201-203. PubMed
19. Shiber, J. R. (2013). Pyomyositis due to anabolic steroid injection. Journal of Emergency Medicine, 44(1), e69-e70. PubMed
20. Williams, J. M., & Howe, N. R. (1994). Benzyl alcohol attenuates the pain of lidocaine injections and prolongs anesthesia. Journal of Dermatologic Surgery and Oncology, 20(11), 730-733. PubMed
21. Wilson, L., & Martin, S. (1999). Benzyl alcohol as an alternative local anesthetic. Annals of Emergency Medicine, 33(5), 495-499. PubMed
22. Depo-Testosterone (testosterone cypionate) prescribing information. Pfizer. DailyMed
23. Testosterone enanthate injection prescribing information. Hikma. DailyMed
24. Sustanon 250 Summary of Product Characteristics. EMC
25. Nebido 1000 mg/4 ml Summary of Product Characteristics. EMC